Pharmaceutical continuous manufacturing (PCM) is a technical solution usually explained by outlining what benefits to expect from implementing this technology, with few to no facts. Development and commercialization of a drug product in a highly regulated market is already risky enough. Using advanced manufacturing technologies is an added risk and often a barrier to implementing any new technology. To lower this perceived risk, a strategic approach is necessary.